GoodRx Holdings (GDRX) Current Assets (2019 - 2026)

GoodRx Holdings (GDRX) has 8 years of Current Assets data on file, last reported at $1.3 billion in Q1 2026.

• For the quarter ending Q1 2026, Current Assets rose 134.44% year-over-year to $1.3 billion; the trailing twelve-month figure through Mar 2026 stood at $1.3 billion (up 134.44% YoY), and the FY2025 full-year result was $643.1 million, down 2.45% from the prior year.
• Current Assets rose to $1.3 billion in Q1 2026, from $643.1 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $1.3 billion in Q1 2026 to a low of $540.2 million in Q1 2025.
• A 5-year average of $805.3 million and a median of $872.8 million in 2023 frame the typical range for Current Assets.
• Across the five-year window, Current Assets plunged 35.32% in 2024 and soared 134.44% in 2026, its largest moves.
• Tracing GDRX's Current Assets over 5 years: stood at $919.7 million in 2022, then dropped by 5.1% to $872.8 million in 2023, then retreated by 24.47% to $659.3 million in 2024, then fell by 2.45% to $643.1 million in 2025, then jumped by 96.93% to $1.3 billion in 2026.
• Business Quant data shows GDRX's Current Assets at $1.3 billion in Q1 2026, $643.1 million in Q4 2025, and $565.5 million in Q3 2025.